Shared vulnerability between seizures and psychosis in cocaine addiction?

Epilepsy and Behavior

Volumn 22, Issue 3, 2011, Pages 596-598

  Rolland, Benjamin ^a,b   Karila, Laurent ^c   Geoffroy, Pierre A ^a,b   Cottencin, Olivier ^a,b  

^a UNIV LILLE   (France)

^b Department of Pharmacology EA 1046 ^*  (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

Cocaine; Dopamine; Kindling effect; N methyl D aspartate; Psychosis; Seizures

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; COCAINE;

ADULT; ANOREXIA NERVOSA; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; COCAINE DEPENDENCE; DISEASE ASSOCIATION; FEMALE; HUMAN; PERSECUTORY DELUSION; PSYCHOSIS; SEIZURE; TONIC CLONIC SEIZURE;

COCAINE-RELATED DISORDERS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PSYCHOTIC DISORDERS; SEIZURES; YOUNG ADULT;

EID: 80054996626     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.08.004     Document Type: Article

References (15)

1. Zagnoni P.G., Albano C. Psychostimulants and epilepsy. Epilepsia 2002, 43(Suppl. 2):28-31.
2. Tang Y.L., Kranzler H.R., Gelernter J., Farrer L.A., Cubells J.F. Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects. Am J Addict 2007, 16:343-351.
3. Dhuna A., Pascual-Leone A., Langendorf F. Chronic, habitual cocaine abuse and kindling-induced epilepsy: a case report. Epilepsia 1991, 32:890-894.
4. Kaminski R.M., Núñez-Taltavull J.F., Budziszewska B., et al. Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain. Neurochem Res 2011, 36:146-152.
5. Ushijima I., Kobayashi T., Suetsugi M., Watanabe K., Yamada M., Yamaguchi K. Cocaine: evidence for NMDA-, beta-carboline- and dopaminergic-mediated seizures in mice. Brain Res 1998, 797:347-350.
6. Brousse G., Vorspan F., Ksouda K., et al. Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions. Med Hypotheses 2010, 75:600-604.
7. Karler R., Calder L.D., Thai L.H., Bedingfield J.B. A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res 1994, 658:8-14.
8. Ron D., Jurd R. The "ups and downs" of signaling cascades in addiction. Sci STKE 2005, 309:re14.
9. Frasca A., Aalbers M., Frigerio F., et al. Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol Dis 2011, 43:507-515.
10. Gangarossa G., Di Benedetto M., O'Sullivan G.J., et al. Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus. PLoS One 2011, 6:e19415.
11. Liu X.Y., Chu X.P., Mao L.M., et al. Modulation of D2R-NR2B interactions in response to cocaine. Neuron 2006, 52:897-909.
12. Seeman P. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. CNS Neurosci Ther 2011, 17:118-132.
13. Centorrino F., Price B.H., Tuttle M., et al. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 2002, 159:109-115.
14. Kennedy A., Wood A.E., Saxon A.J., et al. Quetiapine for the treatment of cocaine dependence: an open-label trial. J Clin Psychopharmacol 2008, 28:221-224.
15. Hamilton J.D., Nguyen Q.X., Gerber R.M., Rubio N.B. Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial. Am J Addict 2009, 18:48-52.